Division of Energy Employees Occupational Illness Compensation (DEEOIC)
COVID-19 DEEOIC FAQs
Question #1: I am a recipient of home health care benefits under EEOICPA, and I am required to have a face-to-face appointment with my physician to renew these benefits. I do not want to leave my house to see my doctor because of COVID-19. I donít want to lose my home health care, are there any flexibilities?
Answer #1: Yes, the DEEOIC staff will review each case individually to determine whether it would be appropriate to extend existing benefits without a face-to-face examination during the COVID-19 pandemic.
Question #2: I have filed a claim with DEEOIC, and they are requesting information within 30 days, but I am unable to see or talk to my doctor. Is there any flexibility on the timeframe?
Answer #2: Yes, DEEOIC will be flexible regarding timeframes for medical evidence on a case-by-case basis if the COVID-19 pandemic prevents you from obtaining the requested information.
Question #3: Do you require claimants to have in-person hearings?
Answer #3: No, DEEOIC has both WebEx and telephone hearings available.
Question #4: I have a claim with the DEEOIC which has been recommended for denial and they tell me that I have 60 days to appeal, but I donít want to leave my house to obtain additional evidence because of COVID-19. Are there any flexibilities on this deadline?
Answer #4: No, because that is a regulatory deadline; however, if you have new evidence to submit at any time after a final decision, you may submit it and the DEEOIC Director may reopen your claim for review.
Question #5: I have to refill my prescription but do not want to risk exposure to the COVID-19. Are there any other options?
Answer #5: Yes, many pharmacies have mail order and delivery options.
Question #6: If I have non-case specific questions regarding DEEOICís handling of COVID-19, where do I turn?
Answer #6: You can submit any question via our public email box at email@example.com. DEEOIC has staff dedicated to reviewing this email box and will ensure that questions related to COVID-19 are given top priority for a rapid response.